Thinksulin
by NSW Agency for Clinical Innovation
Thinksulin - Inpatient Insulin management developed by ACI
| App Name | Thinksulin |
|---|---|
| Developer | NSW Agency for Clinical Innovation |
| Category | Medical |
| Download Size | 5 MB |
| Latest Version | 1.7.141 |
| Average Rating | 0.00 |
| Rating Count | 0 |
| Google Play | Download |
| AppBrain | Download Thinksulin Android app |
Thinksulin was developed by Agency for Clinical Innovation in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2017); clinician and consumer consultations; and clinical expertise.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
Recent changes:
Updates for new Android Versions and to support Android 12+.
SGLT2i information updated throughout the application to reflect the new evidence and guidelines around usage, particularly with regard to the perioperative period.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
Recent changes:
Updates for new Android Versions and to support Android 12+.
SGLT2i information updated throughout the application to reflect the new evidence and guidelines around usage, particularly with regard to the perioperative period.
